nda

Confidential communications and agreements in the context of business relations.

July 29, 2011 13:16

On this edition of IP Counsel, host Attorney Peter Lando, partner at the firm of Lando & Anastasi, LLP, welcomes Jeff Powers, Intellectual Property Counsel for Bausch+Lomb, to discuss best practices in managing the exchange of confidential information. Peter and Jeff discuss the timeline for...

Chief Judge Sleet Adopts Magistrate Judge Stark's Report and Recommendation on Claim Construction

Gregory Williams
July 03, 2010 14:00

By Order dated June 24, 2010, Chief Judge Gregory M. Sleet adopted the Report and Recommendation Regarding Claim Construction entered by Magistrate Judge Leonard P. Stark on May 12, 2010 in The Research Foundation of State of New York, et al. v. Mylan Pharmaceuticals, L.P., Civil Action No....

Judge Robinson Enters Judgment in Favor of Defendants Apotex Upon Finding Patent Claims Invalid Based on Obviousness

Gregory Williams
June 19, 2010 16:53

In Senju Pharmaceutical Co. Ltd., et al. v. Apotex Inc., et al., Civil Action No. 07-779-SLR, the U.S. District Court for the District of Delaware, by and through a memorandum opinion entered by The Honorable Sue L. Robinson on June 14, 2010, entered judgment in favor of defendants, Apotex Inc. and...

Some Things You May Not Know About Generic Drugs

February 20, 2010 14:19

The rising cost of healthcare, increasing drug prices and the restrictive nature of the formularies of many insurers and third party payers is forcing a growing number of Americans to rely almost exclusively on generic prescription drugs. The trouble is that most Americans know very little...

More Regulatory Woes for New Antibiotic

January 30, 2010 18:35

Theravance Inc. announced Thursday US Food and Drug Administration (FDA) regulators are not satisfied with new data on its infection drug candidate telavancin (Vibativ), and indicated that further clinical studies may be required to win marketing approval. Approval of Vibativ has been held up for...